1812721 / To Investigate Whether The Pathological Chemotherapy Response Score (CRS) Is A Surrogate For Survival In Ovarian Cancer – An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated
with Neoadjuvant Chemotherapy and Interval Debulking Surgery

To Investigate Whether The Pathological Chemotherapy Response Score (CRS) Is A Surrogate For Survival In Ovarian Cancer – An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery (Study due to close 01/08/2018)